1.Therapeutic effect of concentrated growth factors combined with self-curing calcium phosphate cement on periodontal intrabony defects:Clinical and radiographic evalua-tion
Xinying WANG ; Xueyuan CHENG ; Yong ZHANG ; Fei LI ; Jinyu DUAN ; Jing QIAO
Journal of Peking University(Health Sciences) 2025;57(1):42-50
Objective:To clarify the role of concentrated growth factors(CGF)in the treatment of periodontal cement defects using calcium phosphate cement(CPC)with self-curing properties.Methods:Thirty-six intrabony defects were randomly divided into two groups.The experimental group received CGF+CPC treatment(n=18),while the control group received CPC treatment alone(n=18).The probing depth,clinical attachment loss,and hard tissue filling as measured by cone beam CT(CBCT)were evaluated at baseline and 1 year postoperatively in both groups,and the levels of major growth factors in CGF and serum were compared[platelet-derived growth factor-BB(PDGF-BB),transforming growth factor-β1(TGF-β1),insulin-like growth factor-1(IGF-1),and vascular endothelial growth factor(VEGF)].Results:At baseline,there were no statistically significant differences in probing depth,clinical attach-ment loss and CBCT measurements between the two groups(P>0.05).At 1 year postoperatively,sig-nificant improvements were observed in parameters mentioned above in both groups(P<0.05).The CGF+CPC group seemed more effective compared with the CPC group in reduction of probing depth[(4.5±1.3)mm vs.(3.2±1.1)mm]and clinical attachment gain[(3.8±0.9)mm vs.(2.0±0.5)mm,P<0.05].Compared with the group treated with CPC alone,the hard tissue filling degree shown by CBCT in the CGF+CPC group was significantly increased[the reduction of the depth of the in-trabony defects was(3.9±1.2)mm vs.(2.1±0.7)mm,respectively,P<0.01].At 1 year post-operatively,the volume of the intrabony defects shown by CBCT in the CGF+CPC group was reduced by(0.031 8±0.004 1)mL,which was significantly more than that in the CPC group[(0.019 7±0.001 2)mL,P<0.05].In addition,the concentration of the main growth factors(PDGF-BB,TGF-β1,IGF-1,and VEGF)in CGF were higher than those in serum(P<0.001).Conclusion:After 1 year of follow-up,the results of the present study indicated that CGF could significantly improve the clinical and radio-logical effects of CPC on the treatment of periodontal intrabony defects.
2.Pharmacokinetics and bioequivalence of rivaroxaban tablet in Chi-nese healthy subjects
Ran XIE ; Lu CHENG ; Shuang ZHOU ; Xueyuan ZHANG ; Xiaoru WANG ; Xia ZHAO ; Xu HE ; Nan ZHAO ; Bo JIA ; Yimin CUI
Chinese Journal of Clinical Pharmacology and Therapeutics 2024;29(11):1295-1299
AIM:To evaluate the bioequivalence of the two rivaroxaban tablets in Chinese healthy subjects.METHODS:Twenty-eight subjects under fasting status and twenty-eight subjects under fed status were enrolled in the study.This study was designed as a four period,fully repetitive,cross-over study.All subjects were administered test(T)and reference(R)rivaroxaban tablets(10 mg)un-der fasting and fed condition respectively.Liquid chromatography-tandem mass spectrometry was used to detect the concentrations of rivaroxaban in plasma.WinNonlin 7.0 was used to calculate the main pharmacokinetic parameters(PK)and to eval-uate the bioequivalence.RESULTS:In fasting group,the main pharmacokinetic parameters of T and R preparation were as follows:Cmax were(186.57±56.41)and(187.61±50.89)ng/mL;AUC0-t were(1 156.21±335.85)and(1 177.59±343.72)h·ng·mL-1;AUC0-∞ were(1 235.77±384.03)and(1223.53±392.10)ng·h·mL-1.The 90%confidential interval(CI)of the three main parameters were 90.81%-105.67%,92.83%-103.85%and 95.04%-107.13%.The upper limit of the 90%CI for the test-to-reference ratio of the within-subject of Cmax,AUC0-t and AUC0-∞ were 1.56,1.41 and 1.73.In fed group,the main pharmacokinetic parameters of T and R preparation were as follows:Cmax were(207.81±45.26)and(211.04±36.62)ng/mL;AUC0-t were(1 271.26±260.92)and(1 233.23±201.85)h·ng·mL-1;AUC0-∞ were(1 290.76±264.90)and(1251.68±203.73)ng·h·mL-1.The 90%CI of the three main parameters were 92.82%-102.28%,97.68%-106.68%and 97.71%-106.68%.The upper limit of the 90%CI for the test-to-reference ratio of the within-subject of Cmax,AUC0t and AUC0-∞were 1.76,1.47 and 1.47.CONCLUSION:The two preparations of rivaroxaban tablets were bioequiva-lent.
3.Pharmacokinetics and bioequivalence of rivaroxaban tablet in Chi-nese healthy subjects
Ran XIE ; Lu CHENG ; Shuang ZHOU ; Xueyuan ZHANG ; Xiaoru WANG ; Xia ZHAO ; Xu HE ; Nan ZHAO ; Bo JIA ; Yimin CUI
Chinese Journal of Clinical Pharmacology and Therapeutics 2024;29(11):1295-1299
AIM:To evaluate the bioequivalence of the two rivaroxaban tablets in Chinese healthy subjects.METHODS:Twenty-eight subjects under fasting status and twenty-eight subjects under fed status were enrolled in the study.This study was designed as a four period,fully repetitive,cross-over study.All subjects were administered test(T)and reference(R)rivaroxaban tablets(10 mg)un-der fasting and fed condition respectively.Liquid chromatography-tandem mass spectrometry was used to detect the concentrations of rivaroxaban in plasma.WinNonlin 7.0 was used to calculate the main pharmacokinetic parameters(PK)and to eval-uate the bioequivalence.RESULTS:In fasting group,the main pharmacokinetic parameters of T and R preparation were as follows:Cmax were(186.57±56.41)and(187.61±50.89)ng/mL;AUC0-t were(1 156.21±335.85)and(1 177.59±343.72)h·ng·mL-1;AUC0-∞ were(1 235.77±384.03)and(1223.53±392.10)ng·h·mL-1.The 90%confidential interval(CI)of the three main parameters were 90.81%-105.67%,92.83%-103.85%and 95.04%-107.13%.The upper limit of the 90%CI for the test-to-reference ratio of the within-subject of Cmax,AUC0-t and AUC0-∞ were 1.56,1.41 and 1.73.In fed group,the main pharmacokinetic parameters of T and R preparation were as follows:Cmax were(207.81±45.26)and(211.04±36.62)ng/mL;AUC0-t were(1 271.26±260.92)and(1 233.23±201.85)h·ng·mL-1;AUC0-∞ were(1 290.76±264.90)and(1251.68±203.73)ng·h·mL-1.The 90%CI of the three main parameters were 92.82%-102.28%,97.68%-106.68%and 97.71%-106.68%.The upper limit of the 90%CI for the test-to-reference ratio of the within-subject of Cmax,AUC0t and AUC0-∞were 1.76,1.47 and 1.47.CONCLUSION:The two preparations of rivaroxaban tablets were bioequiva-lent.
4.Effects of society skill training on frustration and self-esteem of schizophrenics
Yuehong HUA ; Changfeng MA ; Kangying GU ; Yun CHENG ; Juan WANG ; Lili WU ; Xueyuan HOU
Chinese Journal of Modern Nursing 2022;28(35):4963-4967
Objective:To explore the effect of social skill training on the frustration and self-esteem of schizophrenics.Methods:From December 2020 to May 2021, 100 schizophrenics hospitalized in the same ward of the Huai'an Third People's Hospital of Jiangsu Province were selected as the research object by convenience sampling. The patients were randomly divided into the control group and the observation group with 50 cases each. The control group received routine nursing, while the observation group carried out social skills training on the basis of the control group. Before and 8 weeks after the intervention, the frustration, self-esteem and social function of the patients in the two groups were evaluated with the Defeat Scale (DS), Rosenberg Self-esteem Scale (SES) and the Scale of Social Function in Psychosis Inpatients (SSPI) .Results:Before intervention, there was no statistical difference in scores of frustration, self-esteem and social function between the two groups ( P>0.05). After intervention, the scores of frustration in the two groups were lower than those before intervention, and the scores in the observation group were lower than those in the control group, with statistical differences ( P<0.01). The scores of self-esteem and social function in the two groups were higher than those before intervention, and the scores in the observation group were higher than those in the control group, with statistical differences ( P<0.05) . Conclusions:Social skill training can improve the mental state of schizophrenics, reduce their frustration, adjust their self-esteem, and improve their social functions.
5.A systematic review and meta-analysis of severe risk in patients with common chronic diseases and coronavirus disease 2019
Liang WU ; Ping ZHAO ; Jianjun WANG ; Jiaye LIU ; Xiaoyan JIA ; Jing ZHANG ; Honghong LIU ; Song QING ; Yuanjie FU ; Tao YAN ; Xueyuan JIN ; Yongqian CHENG
Chinese Journal of Infectious Diseases 2021;39(1):2-8
Objective:To systematically review the severe risk in common chronic diseases and coronavirus disease 2019 (COVID-19) cases.Methods:PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, Wanfang Database, China Biology Medicine disc, medRxiv, SSRN and ChinaXiv were searched for clinical and epidemiological studies that reported chronic diseases in patients with COVID-19. Only studies of severe COVID-19 in comparison with non-severe controls were included. The prevalence rates of chronic diseases including chronic obstructive pulmonary disease (COPD), diabetes mellitus, hypertension, malignant tumor, cardiovascular diseases, cerebrovascular disease, chronic kidney disease, and chronic liver disease were estimated. Pooled odds ratio ( OR) with 95% confidence interval ( CI) between patients with severe COVID-19 and non-severe groups were calculated. R 3.6.3 software was used for meta-analysis. Results:The search yielded 2 455 articles. A total of 19 eligible comparative studies with 4 792 patients were included in a quantitative analysis. Meta-analysis showed that there was a proportion of 55.0% (95% CI 40.0%-80.0%) male among patients with COVID-19, and the overall pooled prevalence of any chronic diseases in COVID-19 cases was 30.4% (95% CI 24.0%-37.0%). The most prevalent comorbidity was hypertension (16.9%(95% CI 14.0%-20.0%)), followed by diabetes mellitus (8.3%(95% CI 8.0%-9.0%)). The proportion of male patients with severe COVID-19 was higher than that of male patients with non-severe COVID-19 (64.4% vs 52.8%, OR=1.49, 95% CI 1.08-2.05, Z=4.63, P<0.01). The prevalence rates of COPD, cerebrovascular disease, diabetes mellitus, chronic kidney disease, hypertension, cardiovascular diseases and malignant tumor in severe COVID-19 patients were higher than those of non-severe patients ( OR=5.77, 95% CI 3.80-8.74; OR=4.47, 95% CI 2.71-7.38; OR=3.55, 95% CI 2.86-4.40; OR=3.05, 95% CI=1.76-5.28; OR=2.82, 95% CI=1.96-3.97; OR=2.39, 95% CI=1.77-3.23; OR=2.15, 95% CI 1.27-3.66, respectively, Z=8.37, 6.01, 11.60, 4.20, 5.46, 5.71, 3.12, all P<0.01). There was no significant difference in the prevalence of chronic liver disease between severe and non-severe patients ( OR=1.35, 95% CI 0.84-2.17, P=0.11). Conclusion:COVID-19 patients with chronic diseases have higher risk of developing severe disease, and the ORs from high to low are COPD, cerebrovascular disease, diabetes mellitus, chronic kidney disease, hypertension, cardiovascular diseases and malignant tumor.
7.Effects of harpagide on cerebral ischemia and mitochondria mediatedCaspase dependent apoptotic signaling pathway in mice
Yeliang LOU ; Mengjing CHEN ; Ke WANG ; Xueyuan GONG ; Hengpei GONG ; Xiaoming ZHONG ; Rubin CHENG ; Zhen HUANG
Chinese Pharmacological Bulletin 2017;33(4):563-567
Aim To investigate the effects of harpagide on cerebral ischemia and the mitochondria mediated Caspase dependent apoptotic signaling pathway in mice.Methods The MCAO was employed to establish MCAO model.When the models were established, the mice were given harpagide (4, 8, 12 mg·kg-1) and edaravone (3.2 mg·kg-1) [0.1 ml·(10 g)-1] by tail vein injection after MCAO immediately.And the model and control mice were given equivalent normal saline by the same way.After MCAO for 6 h, the behavior, volume of cerebral ischemia and pathological changes in the brain were observed.Westernblot was employed to determine the contents of Cyt C in mitochondrion and pro-caspase-3 in endochylema.Results Compared with the model group, harpagide (4, 8, 12 mg·kg-1) could significantly decrease the increased nerve functional score, brain index, brain water content and volume of cerebral ischemia induced by cerebral ischemia.Harpagide (4, 8, 12 mg·kg-1) could reduce the contents of Cyt C in mitochondrion and pro-caspase-3 in endochylema.Conclusion Harpagide may have protective effect on the cerebral ischemia injury in mice, which might be related to the inhibition of the cerebral mitochondria mediated Caspase dependent apoptotic signaling pathway.
8.Effect of Cordyceps Sinensis from Different Origins on Immune Response in Mice
Wei CHEN ; Xueyuan ZHANG ; Yuejun YANG ; Sijin CHENG ; Guang DU ; Xia GUO
Herald of Medicine 2016;35(7):710-713
Objective To investigate the effect of cordyceps sinensis from different origins on immune response in mice. Methods Cordyceps sinensis from two origins were prepared into powder, and then the mice were divided into high, middle and low dose(0.4,0.2,0.1 g.kg-1)groups, respectively.In addition, purified water was given as the normal control group.Effects of cordyceps from two different origins were observed by detecting spleen lymphocyte proliferation induced by ConA, delayed type hypersensitivity ( DTH) in mice induced by sheep red blood cells ( SRBC ) , the number of antibody-producing cells, carbon clearance and peritoneal macrophages Swallow fluorescent microspheres, as well as the activity of NK cells. Results The ability of spleen lymphocyte proliferation induced by ConA, carbon clearance and peritoneal macrophages Swallow fluorescent microspheres, and the activity of NK cells were significantly enhanced in the middle and high dose group of two different origins cordyceps, compared with normal control group (P<0.05).Additionally, the number of antibody-producing cells was obviously increased in medium dose group of both origins cordyceps and decreased in the high dose group (P<0.05).The middle and high dose Qinghai cordyceps significantly improved DTH in mice, while Tibet cordyceps sinensis had no obvious effect, and there was significant difference (P<0.05) between the high dose group of Qinghai and three dose groups of Tibet Cordyceps sinensis.In addition, levels of serum hemolysin in mice were significantly increased in the middle and high dose group of Qinghai and high dose group of Tibet Cordyceps sinensis (P<0.05), and the differences of corresponding medium and high doses of two origins were significant ( P<0.05) . Conclusion Cordyceps sinensis of both different regions significantly improved the immune response of mice.However, the efficacy between the two origins was roughly equivalent and had no significant difference.
9.The study of totally transumbilical single -port laparoscopic herniorrhaphy and traditional surgery in treat-ment with pediatric indirect inguinal hernia
Chinese Journal of Primary Medicine and Pharmacy 2015;(18):2724-2726
Objective To compare the effect and safety of totally transumbilical single -port laparoscopic herniorrhaphy and traditional surgery in treatment with pediatric indirect inguinal hernia.Methods 100 children with indirect inguinal hernia were divided into control group(n =50)and observation group(n =50).The control group was given to traditional surgery.The observation group was given to totally transumbilical single -port laparoscopic herniorrhaphy.The operation related index,postoperative complications and hernia recurrence rate were compared between the two groups.Results The intraoperatve bleeding,incision length,operation time and hospital stays of the observation group respectively were (18.1 ±5.9)mL,(1.3 ±0.3)cm,(27.4 ±7.9)min and (4.5 ±1.2)d,those of the control group respectively were (38.7 ±8.1)mL,(2.2 ±0.4)cm,(46.7 ±9.2)min and (7.4 ±1.3)d,the difference was statistically significant (t =3.439,3.811,2.872,2.878,P =0.026,0.019,0.045,0.049).The postoperative complications rate of observation the group and the control group were respectively 8.0%(4 /50)and 24.0%(12 /50),the difference was statistically significant(χ2 =4.762,P =0.029).Postoperative follow -up of 1 year,the hernia recurrence rate of the observation group and the control group respectively was 0(0 /50)and 12%(6 /50),the difference was statistically significant (χ2 =6.383,P =0.012).Conclusion Using totally transumbili-cal single -port laparoscopic herniorrhaphy treat with pediatric indirect inguinal hernia is safe and effective.It is ben-eficial to prevent recurrence,and is worth clinical promotion.
10.Analysis of 18 cases which is the nasal sinuses adenoid cystic carcinoma.
Xiaojun JIANG ; Qi LI ; Cheng ZHONG ; Zhendong JIANG ; Xueyuan ZHANG ; Wei YUAN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(11):807-809
OBJECTIVE:
To explore the treatment and possible prognostic factor of nasal sinuses adenoid cystic carcinoma.
METHOD:
Retrospectively analysed the records of 18 patients with complete clinical and pathological data,which including 4 patients given up treatment, 5 patients taken surgical treatment and 9 patients taken surgical treatment as well as radiotherapy and chemotherapy.
RESULT:
Fifty percent of the patients got 2-year survival and 3 cases of death due to intracranial tumor invasion and 2 patients died of the disease distant metastasis.
CONCLUSION
If patients got Nasal sinuses adenoid cystic carcinoma, they should take comprehensive treatment based on surgery, in order to improve the survival rate. The prognosis depends on the tumor early detection and early treatment, the sooner the treatment, the better.
Adult
;
Aged
;
Carcinoma, Adenoid Cystic
;
therapy
;
Female
;
Humans
;
Male
;
Middle Aged
;
Nasal Cavity
;
pathology
;
Paranasal Sinus Neoplasms
;
therapy
;
Prognosis
;
Retrospective Studies

Result Analysis
Print
Save
E-mail